Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pulmonary involvement in scleroderma].

E Tabacu1, S Duţu, P Stoicescu

  • 1Spitalul de Boli Pulmonare, Breaza.

Pneumoftiziologia : Revista Societatii Romane De Pneumoftiziologie
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Superior vena cava syndrome--surgical solution--case report].

Chirurgia (Bucharest, Romania : 1990)·2011
Same author

[International standards for tuberculosis management].

Pneumologia (Bucharest, Romania)·2007
Same author

[Paraneoplastic thrombosis of subclavian and right internal jugular veins. Clinical case].

Pneumologia (Bucharest, Romania)·2001
Same author

[Pulmonary tuberculosis and Kaposi syndrome in HIV positive patient].

Pneumologia (Bucharest, Romania)·2001
Same author

["Pseudomalignant" lung tumors--a permanent diagnostic and treatment challenge].

Pneumologia (Bucharest, Romania)·2000
Same author

[Thyroid tuberculosis--a clinical case].

Pneumologia (Bucharest, Romania)·2000

Scleroderma can cause diffuse interstitial lung disease. In one case, scleroderma-associated lung fibrosis was linked to bronchopulmonary cancer.

Area of Science:

  • Pulmonology
  • Rheumatology
  • Oncology

Background:

  • Scleroderma (systemic sclerosis) is an autoimmune disease characterized by fibrosis affecting skin and internal organs.
  • Pulmonary involvement is a common and serious complication of scleroderma, often manifesting as interstitial lung disease (ILD).

Observation:

  • This paper presents three cases of scleroderma with significant pulmonary manifestations.
  • Diagnostic methods included clinical evaluation, radiography, pulmonary function tests, and histopathology.

Findings:

  • All three cases exhibited diffuse interstitial fibrosis, a specific type of ILD.
  • One patient was also diagnosed with bronchopulmonary cancer, suggesting a potential association.

Implications:

Related Experiment Videos

  • Highlights the importance of comprehensive pulmonary evaluation in scleroderma patients.
  • Underscores the need for further research into the potential link between scleroderma-related ILD and lung cancer risk.